This import alert does not apply to GLP-1 API from manufacturers that, based on an FDA inspection or other FDA evaluation, appear to be in compliance with FDAs rigorous standards for manufacturing practices
When paired with a GLP-1 receptor agonist like tirzepatide, which supports satiety and glucose control, the combination may create a synergistic effect for some individuals. However, she cautions that this isnt a one-size-fits-all treatment, and decisions regarding menopausal hormone therapy and GLP-1s must be personalized and considered in consultation with a licensed provider
Participants were randomised to receive CagriSema, semaglutide 2.4 mg alone, cagrilintide 2.4 mg alone, or placebo, all once-weekly over 68 weeks
Ethics declarations Competing interests The author is employed by, and has financial holdings in, Telik, Inc